×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANTX – an2 therapeutics, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
04:42 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
3/17
04:00 pm
antx
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
Medium
Report
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
3/9
08:12 am
antx
AN2 Therapeutics raises $40M privately [Seeking Alpha]
High
Report
AN2 Therapeutics raises $40M privately [Seeking Alpha]
3/9
07:03 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing [Yahoo! Finance]
3/9
07:00 am
antx
AN2 Therapeutics Announces $40 Million Private Placement Financing
High
Report
AN2 Therapeutics Announces $40 Million Private Placement Financing
3/3
04:11 pm
antx
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
High
Report
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]
3/3
04:00 pm
antx
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
High
Report
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
2/17
07:21 am
antx
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference [Yahoo! Finance]
Low
Report
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/20
04:37 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 19
3/17
04:10 pm
antx
Form S-8 AN2 Therapeutics, Inc.
Medium
Report
Form S-8 AN2 Therapeutics, Inc.
3/17
04:04 pm
antx
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K AN2 Therapeutics, Inc. For: Dec 31
3/17
04:02 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
3/16
04:21 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Commodore Capital LP
3/13
05:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
3/13
04:02 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
3/10
06:03 am
antx
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
High
Report
Form 8-K AN2 Therapeutics, Inc. For: Mar 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: